Company Number: 13833625

Analysis Date: 2025-07-20 13:58 UTC

Financial Health Assessment: VEN-DENS ACCESSORIES LTD

---

1. Financial Health Score: B

Explanation:
VEN-DENS ACCESSORIES LTD shows a solid improvement in its financial position over two years, moving from a modest net asset base (£2,163 in 2023) to a healthier £27,627 in 2024. The company demonstrates positive working capital and growing assets, which are good "vital signs." However, the presence of long-term creditors and relatively low net assets versus liabilities suggest some caution, preventing an "A" grade. Overall, the company is financially stable but has areas to strengthen its resilience.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Fixed Assets	12,760	Indicates investment in long-term resources; a positive sign of asset base development.
Current Assets	179,964	Healthy level of liquid assets and receivables; strong capacity to meet short-term obligations.
Current Liabilities	127,483	Moderate short-term debts; manageable given current assets.
Net Current Assets (Working Capital)	52,481	Positive working capital ("healthy cash flow cushion") indicating ability to cover short-term debts.
Creditors After One Year (Long-term Liabilities)	34,614	Long-term debt present; manageable but should be monitored to avoid liquidity strain.
Net Assets (Equity)	27,627	Positive net worth; company is solvent with assets exceeding liabilities.
Shareholders' Funds	27,627	Equity funded by shareholders, matching net assets, signaling stability.
Employee Count	9 (2024)	Increasing workforce, which implies business growth but also higher operating expenses.

---

3. Diagnosis: Financial Condition Overview

VEN-DENS ACCESSORIES LTD presents the "symptoms" of a growing but still young enterprise. The balance sheet shows a significant increase in current assets and net current assets from 2023 to 2024, reflecting expansion in operations or sales. This "healthy cash flow" suggests the company can meet short-term obligations without distress.

The presence of long-term creditors (£34,614) and accruals indicates the company has taken on some medium-term financing, which is typical for growth phases but requires careful management to avoid liquidity problems—akin to a patient needing ongoing medication but monitored regularly.

Net assets and shareholders' funds are positive, demonstrating solvency, but remain modest relative to the scale of liabilities, which is a "warning sign" to keep leverage in check.

The increase in employee numbers supports the growth narrative but also signals rising overheads, which the company must manage prudently to maintain profitability.

---

4. Recommendations: Path to Financial Wellness

• Strengthen Liquidity Management: Maintain or improve the positive net current assets by carefully managing receivables and payables to sustain "healthy cash flow." Avoid overextending credit terms to customers or stretching payments to suppliers excessively.

• Monitor Long-Term Debt: Keep a close eye on long-term liabilities to ensure they remain serviceable without compromising liquidity. Explore refinancing options if interest rates rise or financial strain appears.

• Enhance Equity Base: Consider reinvesting profits to build shareholders' funds and buffer against future uncertainties, improving the "financial immune system."

• Cost Control with Workforce Growth: As headcount rises, implement strict cost controls and productivity measures to prevent operational expenses from undermining profitability.

• Regular Financial Reviews: Conduct periodic financial health check-ups (quarterly reviews of cash flow, debt levels, and profitability) to detect early "symptoms" of distress.

• Strategic Planning for Growth: Align asset acquisition and workforce expansion with realistic revenue forecasts and market conditions to avoid overextension.

---